Acelrx Pharmaceuticals (ACRX)

Acelrx (ACRX) Cash flow


Acelrx Cash Flow

ACRX's free cash flow for Q1 2023 was $-5.38M. For the 2023 fiscal year, ACRX's free cash flow was decreased by $3.13M and operating cash flow was $-5.28M. See a summary of the company’s cash flow.
Cash Flow
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -24.68M$ -28.33M$ -30.00M$ -38.51M$ -51.18M$ -29.07M
Investing Cash Flow
$ 16.67M$ 36.45M$ -26.12M$ 34.14M$ -36.56M$ -10.88M
Financing Cash Flow
$ -496.00K$ -507.00K$ 41.51M$ 16.96M$ 14.45M$ 75.03M
Cash Flow From Discontinued Operation
Other Cash Adjustment Inside Changein Cash
End Cash Position
$ 63.70M$ 20.27M$ 12.66M$ 27.27M$ 14.68M$ 87.97M
Income Tax Paid Supplemental Data
$ 13.00K$ 13.00K---$ 2.00K
Interest Paid Supplemental Data
$ 824.00K$ 824.00K$ 1.60M$ 2.27M$ 1.71M$ 1.67M
Issuance Of Capital Stock
$ 239.00K-$ 44.72M$ 21.34M$ 1.23M$ 81.53M
Issuance Of Debt
$ -4.27M$ -8.43M-$ 0.00$ 25.00M$ 0.00
Repayment Of Debt
$ -8.43M$ -8.43M$ -8.83M$ -4.67M$ -12.33M$ -7.72M
Free Cash Flow
$ -25.05M$ -28.70M$ -31.83M$ -40.36M$ -54.65M$ -29.89M
Domestic Sales
Foreign Sales
Currency in USD

Acelrx Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis